Have a personal or library account? Click to login
Critical Appraisal of Medical System Performance for STEMI Management – a Comprehensive Analysis of Time Efficiency Cover

Critical Appraisal of Medical System Performance for STEMI Management – a Comprehensive Analysis of Time Efficiency

Open Access
|Mar 2024

References

  1. Nowbar AN, Gitto M, Howard JP, Francis DP, Al-Lamee R. Mortality From Ischemic Heart Disease. Circ Cardiovasc Qual Outcomes. 2019;12(6):e005375. doi: 10.1161/CIRCOUTCOMES.118.005375
  2. Ahuja KR, Saad AM, Nazir S, et al. Trends in Clinical Characteristics and Outcomes in ST-Elevation Myocardial Infarction Hospitalizations in the United States, 2002–2016. Curr Probl Cardiol. 2022;47(12):101005. doi: 10.1016/j.cpcardiol.2021.101005
  3. Pascual I, Hernandez-Vaquero D, Almendarez M, et al. Observed and Expected Survival in Men and Women After Suffering a STEMI. J Clin Med. 2020;9(4):1174. doi: 10.3390/jcm9041174.
  4. Pedersen F, Butrymovich V, Kelbaek H, et al. Short- and long-term cause of death in patients treated with primary PCI for STEMI. J Am Coll Cardiol. 2014;64(20):2101–2108. doi: 10.1016/j.jacc.2014.08.037
  5. Park J, Choi KH, Lee JM, et al. Prognostic Implications of Door-to-Balloon Time and Onset-to-Door Time on Mortality in Patients With ST -Segment-Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention. J Am Heart Assoc. 2019;8(9):e012188. doi: 10.1161/JAHA.119.012188
  6. Nallamothu B, Fox KA, Kennelly BM, et al. Relationship of treatment delays and mortality in patients undergoing fibrinolysis and primary percutaneous coronary intervention. The Global Registry of Acute Coronary Events. Heart. 2007;93(12):1552–1555. doi: 10.1136/hrt.2006.112847
  7. Ghimire G, Gupta A, Hage FG. Guidelines in review: 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction. J Nucl Cardiol. 2014;21(1):190–191. doi: 10.1007/s12350-013-9808-x
  8. Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Rev Esp Cardiol (Engl Ed). 2017;70(12):1082. doi: 10.1016/j.rec.2017.11.010
  9. Fordyce CB, Henry TD, Granger CB. Implementation of Regional ST-Segment Elevation Myocardial Infarction Systems of Care: Successes and Challenges. Interv Cardiol Clin. 2016;5(4):415–425. doi: 10.1016/j.iccl.2016.06.001
  10. Jollis JG, Al-Khalidi HR, Roettig ML, et al. Impact of Regionalization of ST-Segment-Elevation Myocardial Infarction Care on Treatment Times and Outcomes for Emergency Medical Services-Transported Patients Presenting to Hospitals With Percutaneous Coronary Intervention: Mission: Lifeline Accelerator-2. Circulation. 2018;137(4):376–387. doi: 10.1161/CIRCULATIONAHA.117.032446
  11. Jollis JG, Al-Khalidi HR, Roettig ML, et al. Regional Systems of Care Demonstration Project: American Heart Association Mission: Lifeline STEMI Systems Accelerator. Circulation. 2016;134(5):365–374. doi: 10.1161/CIRCULATIONAHA.115.019474
  12. Tatu-Chitoiu G, Arafat R, Deleanu D, Vinereanu D, Udroiu C, Petris A. Impact of the Romanian national programme for interventional therapy in ST-elevation myocardial infarction. EuroIntervention. 2012;8 Suppl P:P126–132. doi: 10.4244/EIJV8SPA22
  13. Thygesen K, Alpert JS, Jaffe AS, et al. Fourth Universal Definition of Myocardial Infarction (2018). Glob Heart. 2018;13(4):305–338. doi: 10.1016/j.gheart.2018.08.004
  14. Schulman S, Angeras U, Bergqvist D, et al. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients. J Thromb Haemost. 2010;8(1):202–204. doi: 10.1111/j.1538-7836.2009.03678.x
  15. Prasad A, Gersh BJ, Mehran R, et al. Effect of Ischemia Duration and Door-to-Balloon Time on Myocardial Perfusion in ST-Segment Elevation Myocardial Infarction: An Analysis From HORIZONS-AMI Trial (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction). JACC Cardiovasc Interv. 2015;8(15):1966–1974. doi: 10.1016/j.jcin.2015.08.031
  16. Garcia-Dorado D, Theroux P, Elizaga J, Galinanes M, Solares J, Riesgo M, et al. Myocardial reperfusion in the pig heart model: infarct size and duration of coronary occlusion. Cardiovasc Res. 1987;21(7):537–544. doi: 10.1093/cvr/21.7.537
  17. Reimer KA, Vander Heide RS, Richard VJ. Reperfusion in acute myocardial infarction: effect of timing and modulating factors in experimental models. Am J Cardiol. 1993;72(19):13G–21G. doi: 10.1016/0002-9149(93)90102-i
  18. Sardar MR, Dawn Abbott J. Myocardial salvage and mortality in STEMI: A race against ischemic time. Catheter Cardiovasc Interv. 2016;87(7):1201–1202. doi: 10.1002/ccd.26599
  19. Solhpour A, Chang KW, Arain SA, et al. Ischemic time is a better predictor than door-to-balloon time for mortality and infarct size in ST-elevation myocardial infarction. Catheter Cardiovasc Interv. 2016;87(7):1194–1200. doi: 10.1002/ccd.26230
  20. Chandrasekhar J, Marley P, Allada C, et al. Symptom-to-Balloon Time is a Strong Predictor of Adverse Events Following Primary Percutaneous Coronary Intervention: Results From the Australian Capital Territory PCI Registry. Heart Lung Circ. 2017;26(1):41–48. doi: 10.1016/j.hlc.2016.05.114
  21. Kim HK, Jeong MH, Ahn Y, et al. Relationship between time to treatment and mortality among patients undergoing primary percutaneous coronary intervention according to Korea Acute Myocardial Infarction Registry. J Cardiol. 2017;69(1):377–382. doi: 10.1016/j.jjcc.2016.09.002
  22. Khowaja S, Ahmed S, Kumar R, et al. Time to think beyond door to balloon time: significance of total ischemic time in STEMI. Egypt Heart J. 2021;73(1):95. doi: 10.1186/s43044-021-00221-1
  23. Doddipalli SR, Rajasekhar D, Vanajakshamma V, Sreedhar Naik K. Determinants of total ischemic time in primary percutaneous coronary interventions: A prospective analysis. Indian Heart J. 2018;70(Suppl 3):S275–S279. doi: 10.1016/j.ihj.2018.05.005
  24. Hedges JR, Feldman HA, Bittner V, et al. Impact of community intervention to reduce patient delay time on use of reperfusion therapy for acute myocardial infarction: rapid early action for coronary treatment (REACT) trial. REACT Study Group. Acad Emerg Med. 2000;7(8):862–872. doi: 10.1111/j.1553-2712.2000.tb02063.x
  25. Blohm MB, Hartford M, Karlson BW, Luepker RV, Herlitz J. An evaluation of the results of media and educational campaigns designed to shorten the time taken by patients with acute myocardial infarction to decide to go to hospital. Heart. 1996;76(5):430–434. doi: 10.1136/hrt.76.5.430
  26. Regueiro A, Rosas A, Kaifoszova Z, et al. Impact of the “ACT NOW. SAVE A LIFE” public awareness campaign on the performance of a European STEMI network. Int J Cardiol. 2015;197:110–112. doi: 10.1016/j.ijcard.2015.06.040
  27. Terkelsen CJ, Sorensen JT, Maeng M, et al. System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention. JAMA. 2010;304(7):763–771. doi: 10.1001/jama.2010.1139
  28. Chakrabarti A, Krumholz HM, Wang Y, Rumsfeld JS, Nallamothu BK, National Cardiovascular Data R. Time-to-reperfusion in patients undergoing interhospital transfer for primary percutaneous coronary intervention in the U.S: an analysis of 2005 and 2006 data from the National Cardiovascular Data Registry. JACC. 2008;51(25):2442–2443. doi: 10.1016/j.jacc.2008.02.071
  29. Nallamothu BK, Bates ER, Herrin J, et al. Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis. Circulation. 2005;111(6):761–767. doi: 10.1161/01.CIR.0000155258.44268.F8
  30. Ikemura N, Kohsaka S, Ueda I, Maekawa Y, Fukuda K. Factors associated with delay in door-to-balloon time in Japan: a report from contemporary multicenter PCI registry. JACC. 2016;67(S13):652. doi: 10.1016/S0735-1097(16)30653-2
  31. Bagai A, Jollis JG, Dauerman HL, et al. Emergency department bypass for ST-Segment-elevation myocardial infarction patients identified with a prehospital electrocardiogram: a report from the American Heart Association Mission: Lifeline program. Circulation. 2013;128(4):352–359. doi: 10.1161/CIRCULATIONAHA.113.002339
  32. Pinto DS, Frederick PD, Chakrabarti AK, et al. Benefit of transferring ST-segment-elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite fibrinolytic declines as delays increase. Circulation. 2011;124(23):2512–2521. doi: 10.1161/CIRCULATIONAHA.111.018549
  33. Boersma E. Primary Coronary Angioplasty vs. Thrombolysis G. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart J. 2006;27(7):779–788. doi: 10.1093/eurheartj/ehi810
  34. Larson DM, Duval S, Sharkey SW, et al. Safety and efficacy of a pharmaco-invasive reperfusion strategy in rural ST-elevation myocardial infarction patients with expected delays due to long-distance transfers. Eur Heart J. 2012;33(10):1232–1240. doi: 10.1093/eurheartj/ehr403
  35. Larson DM, McKavanagh P, Henry TD, Cantor WJ. Reperfusion Options for ST Elevation Myocardial Infarction Patients with Expected Delays to Percutaneous Coronary Intervention. Interv Cardiol Clin. 2016;5(4):439–450. doi: 10.1016/j.iccl.2016.06.004
DOI: https://doi.org/10.2478/jce-2024-0008 | Journal eISSN: 2457-5518 | Journal ISSN: 2457-550X
Language: English
Page range: 27 - 37
Submitted on: Dec 21, 2023
|
Accepted on: Mar 8, 2024
|
Published on: Mar 21, 2024
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2024 Silviu Dumitraşcu, Alexandru Cîrjan, Daniela Bartoş, Ovidiu Chioncel, Mihai Ştefan, Dan Deleanu, published by Asociatia Transilvana de Terapie Transvasculara si Transplant KARDIOMED
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.